BennyJohnsonDO

PubMed

• 1 citations
  Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival.
  Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Mohammad M Fanaeian, Mark Knafl
  JAMA Oncology. 2024-11-01
• 14 citations
  A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results.
  Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa L Johnson
  Nature Medicine. 2024-04-01
• Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling.
  Benny Johnson, Van Morris, Xuemei Wang, Arvind Dasari, Kanwal Raghav
  Cancers. 2024-02-09

Journal Articles

• Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer  
  Benny Johnson, Jonathan M. Loree, Alexandre A. Jacome, Shehara Mendis, Muddassir Syed, Van K. Morris II, Christine M. Parseghian, Arvind Dasari, Shubham Pant, Victoria..., JCO Precision Oncology 2019 :3, 1-10, 8/5/2019
• Co-morbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome  
  Johnson, B., Giri, S., Nunnery, S., Wiedower, E., Jamy, O., Yaghmour, G., Chandler, J., Martin, M., Clinical Lymphoma Myeloma & Leukemia, 1/1/2016
• Emerging Role and Targeting of Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) in Human Malignancies  
  Johnson, B. and Mahadevan D., Clinical Cancer Drugs, 1/1/2015
• Secondary Hemophagocytic Lymphohistiocytosis (SHLH) in the Context of Newly Diagnosed Philadelphia Posi­tive, CD 20+ B-Cell Acute Lymphoblastic Lymphoma (B-ALL): A Cas...  
  Johnson, B. and Johnson, R., J Cancer Biol Res, 1/1/2015
• Discordant tumor response in the treatment of ALK-rearranged non-small cell lung cancer leads to the diagnosis of synchronous multiple primary lung cancer  
  Johnson, B. and Khalil, M., Case Reports in Clinical Medicine, 1/1/2013
• Join now to see all

Abstracts/Posters

• Novel mutational and pathway signatures in relapsed/refractory colorectal cancer patients
  Johnson, B., Cooke, L., Mahadevan, D, GI Cancers Symposium; Poster Session C: Cancers of the Colon, Rectum, and Anus, San Francisco, CA, 1/21/2016
• Novel mutational profiles in relapsed/refractory advanced cancer patients’ pre- and post-targeted therapy
  Mahadevan, D., Johnson, N., Johnson, B., Pandey, P., Chandler, J., Cooke, L., 25th Annual Mayo Clinic Hematology/Oncology Reviews, The Ritz-Carlton, Amelia Island, FL, 1/1/2015
• Comorbidities Drive Outcomes for both Malignancy and Non-Malignancy Associated Hemophagocytic Syndrome
  Johnson, B., Giri S., Nunnery S., Wiedower E., Jamy O., Chandler J., Martin MG., ASH Meetings on Hematologic Malignancies; 57th ASH Annual Meeting and Exposition, Chicago, IL, 2015; Orlando, FL, 2015, 1/1/2015
• Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States’ Rural, Non-Teaching Hospitals
  Jamy O., Giri S., Wiedower E., Johnson B., Nunnery S., Martin MG. , ASH Meetings on Hematologic Malignancies; 57th ASH Annual Meeting and Exposition, Chicago, IL, 2015; Orlando, FL, 2015, 1/1/2015
• Insurance and outcomes for classical Hodgkin lymphoma
  Yaghmour, G., Johnson, B., Lawson R.D., Martin M.G., J Clin Oncol; Proc Amer Soc Clin Onc, Annual Meeting, 1/1/2014
• Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma
  Johnson, B., Khalil, M.F., Blansfield, J., Lin, F., Zhu S., Kirchner, L.H., J Clin Oncol; Proc Amer Soc Clin Onc Gastro Canc Symposium; 10th Annual Meeting of the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, 2013, 1/1/2013
• KOC (K homology domain containing protein overexpressed in cancer) overexpression and progression-free survival after curative intent resection of pancreatic ductal ad...
  Johnson, B., Khalil, M.F., Lin, F., Zhu, S., Kirchner, L.H., J Clin Oncol; Proc Amer Soc Clin Onc, EORTC, Markers in Cancer, Orlando, FL, 2012, 1/1/2012
• Application of an "Early Bundle" for Patients With Severe Nonnosocomial Pneumonia
  Diaz L, Montana de la Cadena P, Baua R, Maguire K, Johnson B, Mejia J, Sartorius J, Simonelli P, Chest, 1/1/2011
• Join now to see all

Lectures

• A phase II study of durvalumab (MEDI4736) (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020